Skip to main content
. 2022 Apr 5;4(6):100483. doi: 10.1016/j.jhepr.2022.100483

Fig. 2.

Fig. 2

Effects of SERPINA1 Pi∗MZ genotype on liver-related outcomes. (A) Fine-Gray competing risk model depicting time to hepatic decompensation, with competing risk of death without hepatic decompensation. (B) Fine-Gray competing risk model depicting time to liver-related death or liver transplant, with competing risk of non-liver-related death. p values are by the Fine-Gray method.